ILiAD Biotechnologies
ILiAD Biotechnologies is utilizing its B-Tech vector platform to develop next generation vaccines to eradicate infectious diseases and improve lives. Its lead candidate, BPZE1, which has completed Phase 2 clinical trials, is the most advanced next generation vaccine for the prevention of whooping cough, a serious illness caused by Bordetella pertussis.
ILiAD Biotechnologies Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Weston, Florida, USA
